MULTIFOCAL TRANSITIONAL CELL CARCINOMA OF THE BLADDER AND UPPER URINARY TRACT: MOLECULAR SCREENING OF CLONAL ORIGIN BY CHARACTERIZING CD44 ALTERNATIVE SPLICING PATTERNS
- 1 September 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 172 (3) , 1127-1129
- https://doi.org/10.1097/01.ju.0000129541.23460.48
Abstract
CD44 is a widely expressed cell surface adhesion molecule in which various isoforms arise from alternative RNA splicing mechanism during cancer initiation. We assessed whether multifocal transitional cell carcinoma of the urothelium is due to field change and/or intraluminal seeding and implantation. In a series of 24 patients with synchronous and/or metachronous multiple urothelial cancers we performed reverse transcription-polymerase chain reaction analysis using a set of primers capable of amplifying all CD44 splice variant isoforms. After polymerase chain reaction products were electrophoresed band intensities with areas corresponding to the major isoforms (that is CD44s, CD44v10 and CD44v8–10) were quantified, and CD44v10-to-CD44s and CD44v8–10-to-CD44s ratios were calculated. Moreover, p53 gene mutations in exons 4 to 11 were screened by direct DNA sequencing. Of these 24 cases 18 showed similar CD44v10-to-CD44s and CD44v8–10-to-CD44s ratios in among multiple urothelial cancers in each case. However, in the remaining 6 cases these ratios were quite different among multiple cancer lesions. Furthermore, different types of p53 mutation were detected among multiple cancer lesions in only 2 of 24 cases, which also indicated different patterns of CD44 alternative splicing. These findings suggest that at least some multiple transitional cell carcinomas of the urothelium seem to be of independent origin based on the analysis of alternative RNA splicing of CD44. Moreover, this hypothesis was further supported by the evaluation of p53 gene mutation.Keywords
This publication has 13 references indexed in Scilit:
- OVER EXPRESSION OF CD44V8-10 IN URINARY EXFOLIATED CELLS AS AN INDEPENDENT PROGNOSTIC PREDICTOR IN PATIENTS WITH UROTHELIAL CANCERJournal of Urology, 2002
- INTERACTION BETWEEN CD44 AND HYALURONIC ACID REGULATES HUMAN PROSTATE CANCER DEVELOPMENTJournal of Urology, 1998
- Altered Expression of CD44 in Human Prostate Cancer During ProgressionAmerican Journal of Clinical Pathology, 1996
- Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.The Journal of Experimental Medicine, 1994
- Metachronous multifocal development of urothelial cancers by intraluminal seedingThe Lancet, 1993
- Expression of CD44R1 adhesion molecule in colon carcinomas and metastasesThe Lancet, 1993
- Novel variants of CD44 arising from alternative splicing: Changes in the CD44 alternative splicing pattern of MCF‐7 breast carcinoma cells treated with hyaluronidaseMolecular Carcinogenesis, 1993
- Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.Proceedings of the National Academy of Sciences, 1992
- p53 function and dysfunctionCell, 1992
- Bladder Cancer — Field versus Clonal OriginNew England Journal of Medicine, 1992